| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000725A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/11/1996 | WO1996000720A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | WO1996000580A1 Health composition |
| 01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
| 01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | CA2193367A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/11/1996 | CA2190977A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
| 01/10/1996 | EP0691342A1 Benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690863A1 Tetracyclic compounds as dopamine agonists |
| 01/10/1996 | EP0690859A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
| 01/10/1996 | EP0690854A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 01/10/1996 | EP0690726A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0613470B1 Novel 4-cinnolinone derivatives, their preparation and application in therapy |
| 01/10/1996 | EP0600949B1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them |
| 01/10/1996 | EP0591255B1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0556329B1 Substituted piperazines as central nervous system agents |
| 01/10/1996 | CN1114651A 3-indolylpiperidine |
| 01/10/1996 | CN1114644A Novel benzylaminoethoxybenzene derivatives, production thereof and use thereof |
| 01/10/1996 | CN1114564A New medicine for curing vascular system disease |
| 01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
| 01/09/1996 | US5482960 Nonpeptide endothelin antagonists |
| 01/09/1996 | US5482958 Method for treating endometriosis |
| 01/09/1996 | US5482957 Azole derivatives, process for their preparation and their use |
| 01/09/1996 | US5482950 Methods for lowering serum cholesterol |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | US5482942 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/09/1996 | US5482941 Quinazolinone antianginal agents |
| 01/09/1996 | US5482925 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 01/09/1996 | CA2153432A1 Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide n-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/09/1996 | CA1337909C Non-peptide renin inhibitors |
| 01/04/1996 | WO1996000288A2 Class bi and ci scavenger receptors |
| 01/04/1996 | WO1996000006A1 Inducible nitric oxide synthase gene for treatment of disease |
| 01/04/1996 | CA2193832A1 Class bi and ci scavenger receptors |
| 01/04/1996 | CA2193827A1 Inducible nitric oxide synthase gene for treatment of disease |
| 01/03/1996 | EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors |
| 01/03/1996 | EP0690048A1 Ortho-amino substituted benzoylguanidines, process for their preparation, their use as medicine or diagnostic and medicines containing them |
| 01/03/1996 | EP0689838A1 Use of diadenosine 5', 5'''- p1, p4 - tetraphosphate for curing ischemic anyocardial disease |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689544A1 Process for production of an imidazole derivative |
| 01/03/1996 | EP0689538A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 01/03/1996 | EP0689536A1 Naphthalene derivatives |
| 01/03/1996 | EP0689450A1 Potassium channel blocking compounds and their use |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0502169B1 Piperazine derivatives |
| 01/03/1996 | CN1114312A Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation, and their use as pharmaceuticals |
| 01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
| 01/03/1996 | CN1030605C 4-substituted phrazolo|3,4-d¨ pyrimidine derivatives |
| 01/02/1996 | US5481030 Phosphonic acid compounds |
| 01/02/1996 | US5480999 Containing an acid and an arginine analogue |
| 01/02/1996 | US5480998 Oxime derivative |
| 01/02/1996 | US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 01/02/1996 | US5480910 Chemical compounds |
| 01/02/1996 | US5480888 1,2-benzoisoselenazol-3-(2h)-(thi)one derivatives |
| 01/02/1996 | US5480882 Benzoxazinone and benzothiazinone derivatives having cardiovascular activity |
| 01/02/1996 | US5480866 Administering hemoglobin |
| 01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
| 01/02/1996 | US5480645 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 01/02/1996 | CA2032904C Blocking agents of edrf effect or formation for the treatment of shock |
| 01/02/1996 | CA1337891C Anf derivatives with novel bridging |
| 12/30/1995 | CA2152878A1 Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 12/29/1995 | CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them |
| 12/28/1995 | WO1995035302A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 12/28/1995 | WO1995035277A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/28/1995 | WO1995035107A1 Endothelin receptor antagonists |
| 12/28/1995 | WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 12/28/1995 | WO1995032203A3 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 12/28/1995 | CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 12/28/1995 | CA2191455A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/27/1995 | EP0688786A1 New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same |
| 12/27/1995 | EP0688771A1 Use of lactam compounds as pharmaceutical agents |
| 12/27/1995 | EP0688766A1 Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 12/27/1995 | EP0688331A1 New sulfated lyso-ganglioside derivatives |
| 12/27/1995 | EP0688330A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 12/27/1995 | EP0688325A1 Phosphonic acid derivatives |
| 12/27/1995 | EP0688319A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 12/27/1995 | EP0688315A1 New heterocyclic compounds, their preparation and their use |
| 12/27/1995 | EP0688220A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/27/1995 | EP0688216A1 Medicament for treating or preventing cerebrovascular diseases |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
| 12/27/1995 | EP0542864B1 Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels |
| 12/27/1995 | EP0471811B1 Allosteric hemoglobin modifiers |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/27/1995 | EP0379549B1 Endotoxin binding protein and uses thereof |
| 12/27/1995 | CN1113915A Chemical compounds |
| 12/27/1995 | CN1030570C Process for preparing 1.5-benzothiazepine derivatives |
| 12/26/1995 | US5478942 Cyclic urea derivatives and pharmaceutical compositions containing these compounds |